Skip to main content

Tabula Rasa HealthCare, Inc.

TRHCDelisted Nov 3, 2023
Industry
Services-Business Services, NEC
SEC CIK
0001651561

Tabula Rasa HealthCare, Inc. was delisted on Nov 3, 2023; its insiders filed their last Form 4 on Nov 14, 2023; 84 institutions reported holding it in 13F filings for Q3 2023, worth $168.0M in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
84
Q3 2023, +3 vs. previous quarter
13F value
$168.0M
Reported value at the end of Q3 2023
Superinvestors holding
0
At the end of Q3 2023

From SEC filings, in USD.

Revenue, FY2022
$299.5M
−9.6% year over year
Net income, FY2022
-$147.5M
No comparable prior period
Free cash flow, FY2022
$5.07M
−58.1% year over year
Revenue, Q2 FY2023
$90.0M
+24.0% year over year

Revenue flow, FY2022

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2022: $147.5M (49.2% of revenue).

Superinvestors holding TRHC, Q3 2023

Go to the superinvestors tab

No superinvestor reported holding TRHC at the end of Q3 2023.

Latest insider trades

See all insider trades

Open-market purchases and sales by Tabula Rasa HealthCare, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 14, 2023 (view filing)6:00 PM ETNov 6-78 daysLateSchrier Derek C and 3 othersDirector, 10% OwnerSSale−1.28M$3,922,024,091.24−$5,031T–0 afterDerivative2 lotsPrice outlier
Dec 14, 2022 (view filing)Dec 122 daysCancro ThomasCHIEF FINANCIAL OFFICERPPurchase+11.5K$4.34+$49.9K+5.8%211.5K after
Dec 13, 2022 (view filing)Dec 94 daysPurcell Michael J.DirectorSSale−10.0K$4.26−$42.6K−10.2%88.5K after
Jul 27, 2022 (view filing)5:17 PM ETJul 252 daysSchrier Derek C and 2 others10% OwnerPPurchase+59.3K$4.28+$253.7K+0.9%6.52M after
Jul 25, 2022 (view filing)4:46 PM ETJul 21-224 daysSchrier Derek C and 2 others10% OwnerPPurchase+1.29M$3.97+$5.14M+25.0%6.46M after8 lots
Mar 8, 2022 (view filing)Mar 44 daysHelling DennisDirectorPPurchase+5.00K$6.17+$30.9K+16.6%35.2K after
Mar 4, 2022 (view filing)Mar 13 daysLateGreenhalgh MichaelCHIEF OPERATING OFFICERPPurchase+2.00K$5.63+$11.3K+1.2%162.6K after
Mar 3, 2022 (view filing)Mar 12 daysTunstall GordonDirectorPPurchase+10.0K$5.50+$55.0K+49.9%30.1K after
Mar 3, 2022 (view filing)Mar 21 dayPurcell Michael J.DirectorPPurchase+10.0K$5.84+$58.4K+26.0%48.5K after
Jan 18, 2022 (view filing)Jan 144 daysGreenhalgh MichaelChief Operating OfficerSSale−2.01K$14.87−$29.9K−1.2%160.6K after

Top 10 13F holders, Q3 2023

See all 84 holders

The largest institutional positions in Tabula Rasa HealthCare, Inc. at the end of Q3 2023; share changes are against Q2 2023.

Institutions holding TRHC in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Indaba Capital Management, L.P.6,521,578$67.2M19.81%00.0%Unchanged
Glazer Capital, LLC1,051,347$10.8M0.71%+1,051,347New
Vanguard Group Inc899,510$9.27M0.00%+72,834+8.8%Added
Beryl Capital Management LLC591,748$6.10M0.78%+591,748New
Berry Street Capital Management LLP550,000$5.67M2.43%+550,000New
BlackRock Inc.371,388$3.83M0.00%−107,050−22.4%Reduced
Qube Research & Technologies Ltd368,220$3.80M0.01%+368,220New
Gabelli Funds LLC355,661$3.67M0.03%+355,661New
Kennedy Capital Management, Inc.300,851$3.10M0.08%−60,472−16.7%Reduced
Water Island Capital LLC269,001$2.77M0.25%+269,001New

1 member of Congress reported 3 trades in Tabula Rasa HealthCare, Inc. since 2020. Newest filings:

  1. Tom Malinowski

    House · NJ · Aug 26, 2021

    Buy$1K-$15K

  2. Tom Malinowski

    House · NJ · Aug 26, 2021

    Sell (partial)$1K-$15K

  3. Tom Malinowski

    House · NJ · Jul 9, 2021

    Sell$1K-$15K